Relay Therapeutics, Inc. (RLAY)
USD 1.83
(-8.75%)
USD 1.83
(-8.75%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -373 Million USD | -24.63% |
| 2022 | -299.27 Million USD | 17.94% |
| 2021 | -364.69 Million USD | -553.63% |
| 2020 | -55.79 Million USD | 33.61% |
| 2019 | -84.04 Million USD | -68.47% |
| 2018 | -49.88 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -112.13 Million USD | -21.62% |
| 2024 Q1 | -92.19 Million USD | 0.0% |
| 2023 Q4 | -92.19 Million USD | -25.31% |
| 2023 Q1 | -101.17 Million USD | -38.88% |
| 2023 FY | -373 Million USD | -24.63% |
| 2023 Q2 | -106.05 Million USD | -4.82% |
| 2023 Q3 | -73.57 Million USD | 30.62% |
| 2022 Q1 | -62.72 Million USD | 7.02% |
| 2022 Q4 | -72.85 Million USD | 15.18% |
| 2022 FY | -299.27 Million USD | 17.94% |
| 2022 Q3 | -85.89 Million USD | -10.39% |
| 2022 Q2 | -77.81 Million USD | -24.06% |
| 2021 FY | -364.69 Million USD | -553.63% |
| 2021 Q3 | -60.99 Million USD | 68.49% |
| 2021 Q4 | -67.45 Million USD | -10.6% |
| 2021 Q2 | -193.58 Million USD | -356.5% |
| 2021 Q1 | -42.4 Million USD | -221.2% |
| 2020 Q1 | -26.45 Million USD | -2.42% |
| 2020 Q2 | -27.71 Million USD | -4.77% |
| 2020 Q4 | 34.98 Million USD | 195.58% |
| 2020 Q3 | -36.6 Million USD | -32.06% |
| 2020 FY | -55.79 Million USD | 33.61% |
| 2019 Q4 | -25.83 Million USD | -17.92% |
| 2019 FY | -84.04 Million USD | -68.47% |
| 2019 Q3 | -21.9 Million USD | -10.06% |
| 2019 Q2 | -19.9 Million USD | -21.36% |
| 2019 Q1 | -16.4 Million USD | 0.0% |
| 2018 FY | -49.88 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -237.2 Million USD | -57.247% |
| Alkermes plc | 414.12 Million USD | 190.07% |
| Agenus Inc. | -159.54 Million USD | -133.784% |
| Aptorum Group Limited | -10.52 Million USD | -3444.505% |
| Ardelyx, Inc. | -63.27 Million USD | -489.481% |
| Dyadic International, Inc. | -8.22 Million USD | -4432.343% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -31191.946% |
| Lantern Pharma Inc. | -17.87 Million USD | -1986.413% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -1756.664% |
| Novavax, Inc. | -566.51 Million USD | 34.158% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -411.106% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -353.793% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -1820.847% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -3431.194% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -602.099% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | 1.97% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1434.562% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -884.975% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -189.174% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -344.503% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -2026.689% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -747.535% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -1401.369% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -168.285% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | -32.187% |
| AlloVir, Inc. | -181.33 Million USD | -105.701% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -81.949% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1174.865% |
| Bicycle Therapeutics plc | -189.94 Million USD | -96.372% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -117.136% |
| ChromaDex Corporation | -5.59 Million USD | -6561.904% |
| Chimerix, Inc. | -93.06 Million USD | -300.795% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -727.467% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -221.388% |
| CRISPR Therapeutics AG | -222.53 Million USD | -67.612% |
| Precision BioSciences, Inc. | -43.73 Million USD | -752.844% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -95.789% |
| Fortress Biotech, Inc. | -142.34 Million USD | -162.045% |
| Fortress Biotech, Inc. | -142.34 Million USD | -162.045% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -281.804% |
| ImmuCell Corporation | -5.74 Million USD | -6389.126% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -177.47% |
| Immix Biopharma, Inc. | -16.14 Million USD | -2210.869% |
| Incyte Corporation | 620.52 Million USD | 160.11% |
| Innoviva, Inc. | 176.7 Million USD | 311.081% |
| IO Biotech, Inc. | -91.44 Million USD | -307.904% |
| Jaguar Health, Inc. | -34.29 Million USD | -987.749% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -119.488% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 3223.43% |
| ContextLogic Inc. | -328 Million USD | -13.72% |
| MiMedx Group, Inc. | 37.11 Million USD | 1104.957% |
| MEI Pharma, Inc. | 14.54 Million USD | 2664.984% |
| NextCure, Inc. | -67.63 Million USD | -451.473% |
| Onconetix, Inc. | -36.03 Million USD | -935.116% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -794.184% |
| Opthea Limited | -191.84 Million USD | -94.43% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -13454.641% |
| Vaxcyte, Inc. | -468.04 Million USD | 20.306% |
| PDS Biotechnology Corporation | -43.04 Million USD | -766.53% |
| Precigen, Inc. | -88.92 Million USD | -319.464% |
| Pharming Group N.V. | -4.87 Million USD | -7544.157% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -122.937% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -1153.529% |
| PureTech Health plc | -146.19 Million USD | -155.132% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -1720.311% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -58.321% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1434.562% |
| Sangamo Therapeutics, Inc. | -274 Million USD | -36.129% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -1172.82% |
| Acelyrin, Inc. | -422.06 Million USD | 11.625% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -2892507.488% |
| Summit Therapeutics Inc. | -89.73 Million USD | -315.664% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -906.367% |
| Senti Biosciences, Inc. | -92.72 Million USD | -302.256% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -224.989% |
| Elevation Oncology, Inc. | -45.44 Million USD | -720.772% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -988.511% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -9362.087% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -11696.331% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -1029.584% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -4287.719% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -448.562% |
| Seer, Inc. | -103.46 Million USD | -260.515% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -467.223% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -418.538% |
| ESSA Pharma Inc. | -32.13 Million USD | -1060.761% |
| GlycoMimetics, Inc. | -39.27 Million USD | -849.706% |
| GT Biopharma, Inc. | -13.57 Million USD | -2647.496% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -70.148% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | -706.382% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 529.664% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -557.165% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -624.187% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -3653.404% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | 26.038% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -5307.364% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -635.802% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -43.65% |
| Aptose Biosciences Inc. | -52.35 Million USD | -612.43% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -2486.546% |
| Soligenix, Inc. | -7.69 Million USD | -4745.452% |
| Century Therapeutics, Inc. | -146.54 Million USD | -154.528% |
| Kura Oncology, Inc. | -165.8 Million USD | -124.964% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -299.11% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -4383.712% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -14930.389% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -5652.622% |
| Autolus Therapeutics plc | -195.02 Million USD | -91.255% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -340.601% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -406.367% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -1664.845% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -64.292% |
| GRI Bio, Inc. | -11.38 Million USD | -3175.665% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -8160.043% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -184.314% |
| IGM Biosciences, Inc. | -263.46 Million USD | -41.577% |
| INmune Bio, Inc. | -29.74 Million USD | -1154.161% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -237.206% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -879.637% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -2234.261% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -2265.126% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -510.495% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -246.906% |
| Atara Biotherapeutics, Inc. | -276 Million USD | -35.142% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -83.564% |
| Verastem, Inc. | -92.08 Million USD | -305.065% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -691.344% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -102.558% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -215.087% |
| Histogen Inc. | -10.64 Million USD | -3404.651% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -2310.813% |
| Surrozen, Inc. | -45.78 Million USD | -714.766% |
| Organovo Holdings, Inc. | -15.08 Million USD | -2372.491% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -7227.755% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -529.202% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -627.181% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -1375.475% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -4786.777% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -117.768% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -669.898% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -376.952% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -2350.598% |
| Apollomics, Inc. | -54.83 Million USD | -580.235% |
| Amarin Corporation plc | -67.58 Million USD | -451.873% |
| Mesoblast Limited | -58.79 Million USD | -534.418% |
| Turnstone Biologics Corp. | -59.03 Million USD | -531.861% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -125.337% |
| Synaptogenix, Inc. | -8.31 Million USD | -4386.487% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -2457.247% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -306.801% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -7684.674% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -4123.645% |
| Exelixis, Inc. | 170.88 Million USD | 318.275% |
| Better Therapeutics, Inc. | -38.26 Million USD | -874.858% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -140.547% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | 27.87% |
| NLS Pharmaceutics AG | -11.8 Million USD | -3059.126% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -4538.204% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -1143.624% |
| Gritstone bio, Inc. | -154.63 Million USD | -141.215% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -441.671% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -2078.35% |
| Avid Bioservices, Inc. | -18.67 Million USD | -1897.002% |
| Insmed Incorporated | -709.62 Million USD | 47.437% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -2277.343% |
| MediWound Ltd. | -15.29 Million USD | -2339.503% |
| OmniAb, Inc. | -69.41 Million USD | -437.317% |
| Alector, Inc. | -151.74 Million USD | -145.815% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -245.425% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -615.272% |
| Zai Lab Limited | -366.57 Million USD | -1.753% |
| Revance Therapeutics, Inc. | -316.77 Million USD | -17.748% |
| Aura Biosciences, Inc. | -84.99 Million USD | -338.87% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -51.935% |
| Immunic, Inc. | -99.22 Million USD | -275.921% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -160.551% |
| Veracyte, Inc. | -85.79 Million USD | -334.757% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | -32.356% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -2524.912% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -5315.257% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -1884.822% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 164.468% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -1365.446% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 1061.291% |
| TG Therapeutics, Inc. | 20.63 Million USD | 1907.784% |
| Galecto, Inc. | -39.9 Million USD | -834.72% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -786.533% |
| Fortrea Holdings Inc. | 63.1 Million USD | 691.125% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -165.584% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -1191.641% |
| XBiotech Inc. | -37.51 Million USD | -894.401% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -441.671% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -455.721% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -245.671% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1352.945% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -599.917% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 34.47% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -375.208% |
| Vaxxinity, Inc. | -58.28 Million USD | -539.959% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -259.66% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -1576.168% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -331.633% |
| NexImmune, Inc. | -29.19 Million USD | -1177.726% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -6536.855% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -2458.057% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 109.216% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -1365.101% |
| Scopus BioPharma Inc. | -11.71 Million USD | -3083.986% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -193.557% |
| Ainos, Inc. | -13.2 Million USD | -2724.389% |
| Pluri Inc. | -22.15 Million USD | -1583.365% |
| Prothena Corporation plc | -191.03 Million USD | -95.251% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -170.215% |
| Celularity Inc. | -192.28 Million USD | -93.981% |
| Rallybio Corporation | -78.93 Million USD | -372.559% |
| Cue Biopharma, Inc. | -52.14 Million USD | -615.258% |
| MeiraGTx Holdings plc | -137.06 Million USD | -172.142% |
| Omeros Corporation | -164.53 Million USD | -126.706% |
| Humacyte, Inc. | -100.04 Million USD | -272.825% |
| Immunocore Holdings plc | -59.64 Million USD | -525.325% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -1909.807% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -1423.506% |
| Blueprint Medicines Corporation | -486.27 Million USD | 23.295% |
| CalciMedica, Inc. | -21.87 Million USD | -1605.143% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -399.598% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -183.683% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -117.753% |
| Sana Biotechnology, Inc. | -326.9 Million USD | -14.102% |
| Pulmatrix, Inc. | -14.74 Million USD | -2430.529% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -943.503% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -319.733% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | 27.614% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -452.175% |
| Cytokinetics, Incorporated | -496.2 Million USD | 24.829% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -983.704% |
| Nutriband Inc. | -4.87 Million USD | -7556.11% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -755.25% |
| Vor Biopharma Inc. | -126.03 Million USD | -195.947% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 108.793% |
| Evogene Ltd. | -26.39 Million USD | -1313.361% |
| ProKidney Corp. | -151.52 Million USD | -146.169% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -477.981% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -4749.041% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 38.588% |
| CorMedix Inc. | -48.95 Million USD | -661.881% |
| BioLineRx Ltd. | -49.69 Million USD | -650.594% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -226.697% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -879.723% |
| Atai Life Sciences N.V. | -125.47 Million USD | -197.28% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -356.888% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -358.18% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -49.806% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1113.403% |
| MediciNova, Inc. | -9.9 Million USD | -3667.576% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -195.158% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -5050.184% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1294.761% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -60.897% |
| Biomea Fusion, Inc. | -126.13 Million USD | -195.715% |
| PTC Therapeutics, Inc. | -349.4 Million USD | -6.754% |
| Mereo BioPharma Group plc | -28.41 Million USD | -1212.641% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -95.197% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -62.206% |
| Absci Corporation | -115.51 Million USD | -222.902% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1252.086% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -230.477% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -54.029% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -1380.394% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -79.332% |
| Allakos Inc. | -196.05 Million USD | -90.252% |
| Imunon, Inc. | -21.03 Million USD | -1673.62% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -237.056% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 447.682% |
| BioAtla, Inc. | -129.68 Million USD | -187.616% |
| NLS Pharmaceutics AG | -11.8 Million USD | -3059.126% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -2254.352% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | -13.811% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -793.242% |
| XOMA Corporation | -41.84 Million USD | -791.321% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -254.438% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -207.009% |
| aTyr Pharma, Inc. | -54.91 Million USD | -579.182% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -326.642% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -115.769% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -46.591% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -1637.632% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -4441.716% |
| Akari Therapeutics, Plc | -16.8 Million USD | -2119.445% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -4217911.247% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 210.494% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -5608.582% |
| UroGen Pharma Ltd. | -65.53 Million USD | -469.153% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -317.796% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -5035.61% |
| Orgenesis Inc. | -53.63 Million USD | -595.428% |
| Entera Bio Ltd. | -8.89 Million USD | -4095.254% |
| GH Research PLC | -41.22 Million USD | -804.857% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -1350.91% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -349.111% |
| Xencor, Inc. | -138.63 Million USD | -169.044% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -7136.279% |
| Replimune Group, Inc. | -234.77 Million USD | -58.877% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -1635.601% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -2573.452% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -5608.582% |
| Portage Biotech Inc. | -18.25 Million USD | -1943.5% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -5050.184% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -255.37% |
| OncoCyte Corporation | -25.13 Million USD | -1383.927% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -3199.467% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -3155.634% |
| Purple Biotech Ltd. | 22.27 Million USD | 1774.824% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -4865.389% |
| scPharmaceuticals Inc. | -55.39 Million USD | -573.334% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -1873.786% |
| HilleVax, Inc. | -133.34 Million USD | -179.726% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -2995.693% |
| Tharimmune, Inc. | -9.45 Million USD | -3844.911% |
| Genprex, Inc. | -31.07 Million USD | -1100.3% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -98.2% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -1088.769% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -48658.17% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -6747.908% |
| OKYO Pharma Limited | -15.74 Thousand USD | -2368194.568% |
| Savara Inc. | -60 Million USD | -521.594% |
| Curis, Inc. | -48.33 Million USD | -671.745% |
| Daré Bioscience, Inc. | -30.83 Million USD | -1109.473% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -7049.319% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -5025.739% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -1268.807% |
| BeiGene, Ltd. | -1.2 Billion USD | 69.116% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -1770.678% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | 23.438% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -298.283% |
| Erasca, Inc. | -141.52 Million USD | -163.558% |
| bluebird bio, Inc. | -244.26 Million USD | -52.705% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -8139.499% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 291.832% |
| DBV Technologies S.A. | -76.43 Million USD | -388.015% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -8139.499% |
| Moderna, Inc. | -4.23 Billion USD | 91.201% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -775.402% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -5764.78% |
| Molecular Templates, Inc. | -10.46 Million USD | -3463.921% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -454.754% |
| Travere Therapeutics, Inc. | -376.74 Million USD | 0.994% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -160.273% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -617.404% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -141.358% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -79.215% |
| MacroGenics, Inc. | -168.24 Million USD | -121.702% |
| RenovoRx, Inc. | -11.39 Million USD | -3173.078% |
| Adicet Bio, Inc. | -152.03 Million USD | -145.333% |
| Prime Medicine, Inc. | -191.29 Million USD | -94.99% |
| Aditxt, Inc. | -26.06 Million USD | -1331.179% |
| Adagene Inc. | -23.71 Million USD | -1472.522% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5002.531% |
| Quantum-Si incorporated | -111.17 Million USD | -235.519% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -1078.589% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -2458.691% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 405.703% |
| SciSparc Ltd. | -5.77 Million USD | -6361.112% |
| Vericel Corporation | -6.46 Million USD | -5670.421% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -4208.819% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -1513.351% |
| Generation Bio Co. | -138.56 Million USD | -169.192% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -349.235% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -331.413% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -54.707% |
| Invivyd, Inc. | -207.78 Million USD | -79.514% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -3877.18% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 1836.418% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -3525.936% |
| 2seventy bio, Inc. | -216.7 Million USD | -72.125% |
| ADMA Biologics, Inc. | 21.63 Million USD | 1824.297% |
| Clene Inc. | -40.54 Million USD | -820.079% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -1449.141% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -580.707% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1294.761% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | -6.553% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -915.463% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 2420.085% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -259.684% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -996.994% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -119.054% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 45.492% |
| Evaxion Biotech A/S | -22.19 Million USD | -1580.407% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -352.769% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -67.172% |
| Trevena, Inc. | -35.28 Million USD | -957.017% |
| Surrozen, Inc. | -45.78 Million USD | -714.766% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -366.571% |
| Cingulate Inc. | -22.75 Million USD | -1538.898% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 5078.644% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -735.068% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -4430.03% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -263.697% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -408.32% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -500.896% |
| Clearmind Medicine Inc. | -8.74 Million USD | -4167.075% |
| Kronos Bio, Inc. | -121.83 Million USD | -206.164% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -389.527% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -12617.419% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -269.941% |
| Statera Biopharma, Inc. | -98.34 Million USD | -279.282% |
| ImmunityBio, Inc. | -362.25 Million USD | -2.968% |
| Korro Bio, Inc. | -84.53 Million USD | -341.243% |
| Kineta, Inc. | -15.72 Million USD | -2272.321% |
| BioVie Inc. | -32.17 Million USD | -1059.12% |
| Codexis, Inc. | -68.06 Million USD | -447.973% |
| Celularity Inc. | -192.28 Million USD | -93.981% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -67.559% |
| Celcuity Inc. | -66.23 Million USD | -463.186% |
| Virax Biolabs Group Limited | -6.49 Million USD | -5641.577% |
| Cibus, Inc. | -318.88 Million USD | -16.971% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -767.442% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -1002.116% |
| IN8bio, Inc. | -30.33 Million USD | -1129.522% |
| Kodiak Sciences Inc. | -277.32 Million USD | -34.501% |
| Annexon, Inc. | -143.72 Million USD | -159.527% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -201.314% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -476.989% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -1491.025% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | -5.448% |
| Eyenovia, Inc. | -25.4 Million USD | -1368.131% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 1242.77% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -6606.221% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -371.358% |
| Arcellx, Inc. | -89.88 Million USD | -314.998% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -721.369% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -171.852% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -1099.01% |
| Moolec Science SA | -6.65 Million USD | -5505.815% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -510.095% |
| Geron Corporation | -193.94 Million USD | -92.324% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -762.368% |
| Royalty Pharma plc | 1.49 Billion USD | 124.997% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -127.215% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -3898.771% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -1603.612% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -118.184% |
| Humacyte, Inc. | -100.04 Million USD | -272.825% |
| Structure Therapeutics Inc. | -102.77 Million USD | -262.929% |
| 89bio, Inc. | -151.2 Million USD | -146.687% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -365.482% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -2465.337% |
| Genelux Corporation | -24.16 Million USD | -1443.555% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -999.549% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -117.176% |
| Notable Labs, Ltd. | -14.65 Million USD | -2444.859% |
| Liquidia Corporation | -73.38 Million USD | -408.285% |
| Mustang Bio, Inc. | -50.72 Million USD | -635.323% |
| Immunovant, Inc. | -282.7 Million USD | -31.938% |
| Quantum-Si incorporated | -111.17 Million USD | -235.519% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -377.574% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -1653.891% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -265.643% |
| Acasti Pharma Inc. | -11.31 Million USD | -3197.383% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -1527.321% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -2234.261% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -74.255% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -10066.058% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -2247.979% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -1179.281% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -801.315% |
| PepGen Inc. | -84.76 Million USD | -340.035% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -1158.817% |
| United Therapeutics Corporation | 1.18 Billion USD | 131.479% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1529.034% |
| Solid Biosciences Inc. | -104.31 Million USD | -257.571% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -1036.914% |
| Immuneering Corporation | -58.41 Million USD | -538.558% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -7227.755% |
| Silo Pharma, Inc. | -3.85 Million USD | -9574.26% |
| Belite Bio, Inc | -31.66 Million USD | -1077.845% |
| XOMA Corporation | -41.84 Million USD | -791.321% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -452.429% |
| Bionomics Limited | -17.89 Billion USD | 97.915% |
| Apogee Therapeutics, Inc. | -93 Million USD | -301.062% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1145.404% |
| uniQure N.V. | -282.87 Million USD | -31.862% |
| Cassava Sciences, Inc. | -105.95 Million USD | -252.03% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5002.531% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -188.022% |
| Forte Biosciences, Inc. | -32.48 Million USD | -1048.187% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -4389.241% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -1168.923% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -6606.221% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -2524.912% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -4096.198% |
| Altimmune, Inc. | -95.92 Million USD | -288.829% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -407.524% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1145.404% |
| Compugen Ltd. | -12.99 Million USD | -2770.998% |
| Peak Bio, Inc. | -1356.23 USD | -27502609.717% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -651.955% |
| Benitec Biopharma Inc. | -22.49 Million USD | -1558.515% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -53.939% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -1153.95% |
| Zura Bio Limited | -62.63 Million USD | -495.485% |
| PolyPid Ltd. | -22.86 Million USD | -1531.172% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -2191.718% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -1153.95% |
| Instil Bio, Inc. | -159.16 Million USD | -134.342% |
| argenx SE | -425.04 Million USD | 12.245% |
| Immunome, Inc. | -109.53 Million USD | -240.546% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -640.623% |
| Verona Pharma plc | -67.83 Million USD | -449.897% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -1331.312% |
| Shattuck Labs, Inc. | -91.95 Million USD | -305.624% |
| CervoMed Inc. | -7.81 Million USD | -4674.159% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -410.19% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -2700.09% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -674.277% |
| Moolec Science SA | -6.65 Million USD | -5505.815% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -2167.692% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -175.833% |
| AnaptysBio, Inc. | -164.41 Million USD | -126.87% |
| Design Therapeutics, Inc. | -78.19 Million USD | -377.043% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -328.534% |
| NeurAxis, Inc. | -6.66 Million USD | -5496.823% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -821.01% |
| Lumos Pharma, Inc. | -36.61 Million USD | -918.736% |
| Achilles Therapeutics plc | -75.25 Million USD | -395.648% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -1331.312% |
| 180 Life Sciences Corp. | -13.47 Million USD | -2667.576% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 7333.854% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -12617.419% |
| Nutriband Inc. | -4.87 Million USD | -7556.11% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -236.703% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -572.69% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -633.732% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -464.305% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -589.17% |
| Palisade Bio, Inc. | -13.07 Million USD | -2753.864% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -721.423% |
| Beam Therapeutics Inc. | -176.48 Million USD | -111.349% |
| Neurogene Inc. | -55.58 Million USD | -571.068% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -241.719% |
| AEON Biopharma, Inc. | -48.42 Million USD | -670.2% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -285.689% |
| Sesen Bio, Inc. | -25.9 Million USD | -1339.654% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -346.551% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -2863.399% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | 19.011% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -414.916% |
| Athira Pharma, Inc. | -125.46 Million USD | -197.292% |
| Vaccinex, Inc. | -22.88 Million USD | -1529.889% |
| HCW Biologics Inc. | -25.71 Million USD | -1350.393% |
| XOMA Corporation | -41.84 Million USD | -791.321% |
| Nektar Therapeutics | -137.42 Million USD | -171.421% |
| Arvinas, Inc. | -401.5 Million USD | 7.098% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -4217911.247% |
| Merus N.V. | -156.54 Million USD | -138.267% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -272.029% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -977.412% |
| Rezolute, Inc. | -70.42 Million USD | -429.657% |
| Clene Inc. | -40.54 Million USD | -820.079% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -2177.379% |
| BeyondSpring Inc. | -23.11 Million USD | -1513.741% |
| Synlogic, Inc. | -55.16 Million USD | -576.202% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -1980.428% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -3346.046% |
| Peak Bio, Inc. | -1356.23 USD | -27502609.717% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -820.919% |
| Krystal Biotech, Inc. | -109.72 Million USD | -239.935% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -187.942% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | -8.742% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -7759.328% |
| MannKind Corporation | 8.67 Million USD | 4398.225% |
| Ikena Oncology, Inc. | -75.41 Million USD | -394.583% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -3766.487% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -454.812% |
| Gossamer Bio, Inc. | -183.75 Million USD | -102.983% |
| CohBar, Inc. | -12.38 Million USD | -2910.906% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -635.352% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1252.086% |
| Legend Biotech Corporation | -439.48 Million USD | 15.128% |
| Mural Oncology plc | -194.63 Million USD | -91.638% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -455.531% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -2210.274% |
| Disc Medicine, Inc. | -91.12 Million USD | -309.328% |
| Champions Oncology, Inc. | -7.35 Million USD | -4970.691% |
| REGENXBIO Inc. | -268.12 Million USD | -39.113% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -3380.066% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -568.986% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -857.376% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -226.172% |
| Vaxart, Inc. | -83.34 Million USD | -347.527% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -4277.93% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -771.616% |
| Cellectis S.A. | -106.62 Million USD | -249.821% |
| Longeveron Inc. | -21.02 Million USD | -1673.741% |
| Repare Therapeutics Inc. | -116.22 Million USD | -220.932% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -39.271% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -393.093% |
| Revolution Medicines, Inc. | -487.18 Million USD | 23.438% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -5507.336% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -748.614% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -400.067% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -435.65% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -3287.522% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 108.659% |
| Denali Therapeutics Inc. | -196.69 Million USD | -89.63% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -4208.819% |
| Veru Inc. | -93.78 Million USD | -297.73% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -1498.868% |
| Cingulate Inc. | -22.75 Million USD | -1538.898% |
| Passage Bio, Inc. | -108.38 Million USD | -244.131% |
| Context Therapeutics Inc. | -25.07 Million USD | -1387.679% |
| Exicure, Inc. | -14.99 Million USD | -2387.33% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -81.012% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -818.764% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -3738.658% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -102.325% |
| Nuvalent, Inc. | -149.49 Million USD | -149.512% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -4439.641% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -320.372% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -1695.514% |
| OmniAb, Inc. | -69.41 Million USD | -437.317% |
| Anew Medical, Inc. | -1.3 Million USD | -28573.78% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -2820.68% |
| Lipocine Inc. | -17.93 Million USD | -1980.201% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -444.422% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -389.81% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -879.637% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -843.659% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -1566.369% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 35.673% |
| Ocugen, Inc. | -65.53 Million USD | -469.196% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -297.375% |
| Q32 Bio Inc. | -92.1 Million USD | -304.986% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -1639.82% |
| Alumis Inc. Common Stock | -158.17 Million USD | -135.816% |
| Equillium, Inc. | -14.52 Million USD | -2468.517% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -497.699% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -4619.518% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -1877.195% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -694.445% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -243.887% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -3016.12% |
| Dominari Holdings Inc. | -21.79 Million USD | -1611.323% |
| Edesa Biotech, Inc. | -9.22 Million USD | -3944.343% |
| vTv Therapeutics Inc. | -25.5 Million USD | -1362.63% |
| Bio-Techne Corporation | 206.68 Million USD | 280.467% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | 4.722% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 294.24% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -181.984% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -871.582% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -146.855% |
| Nkarta, Inc. | -131.65 Million USD | -183.327% |
| BioCardia, Inc. | -11.64 Million USD | -3103.367% |
| Iterum Therapeutics plc | -47.46 Million USD | -685.793% |